Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis

Kastrati, 2007, Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents, N Engl J Med, 356, 1030, 10.1056/NEJMoa067484 Stettler, 2007, Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis, Lancet, 370, 937, 10.1016/S0140-6736(07)61444-5 Stefanini, 2013, Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials, Lancet, 382, 1879, 10.1016/S0140-6736(13)61782-1 Palmerini, 2012, Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis, Lancet, 379, 1393, 10.1016/S0140-6736(12)60324-9 Taniwaki, 2014, J Am Coll Cardiol, 63, 1617, 10.1016/j.jacc.2013.12.036 Cassese, 2014, Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography, Heart, 100, 153, 10.1136/heartjnl-2013-304933 Go, 2014, Heart disease and stroke statistics—2014 update: a report from the American Heart Association, Circulation, 129, e28 Alfonso, 2014, Current treatment of in-stent restenosis, J Am Coll Cardiol, 63, 2659, 10.1016/j.jacc.2014.02.545 Higgins, 2011, The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, BMJ, 343, d5928, 10.1136/bmj.d5928 DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 Cohen, 1988 Cipriani, 2013, Conceptual and technical challenges in network meta-analysis, Ann Intern Med, 159, 130, 10.7326/0003-4819-159-2-201307160-00008 Caldwell, 2005, Simultaneous comparison of multiple treatments: combining direct and indirect evidence, BMJ, 331, 897, 10.1136/bmj.331.7521.897 Lu, 2004, Combination of direct and indirect evidence in mixed treatment comparisons, Stat Med, 23, 3105, 10.1002/sim.1875 Chaimani, 2013, Graphical tools for network meta-analysis in STATA, PLoS One, 8, e76654, 10.1371/journal.pone.0076654 White, 2011, Multivariate random-effects meta-regression: updates to mvmeta, Stata J, 11, 255, 10.1177/1536867X1101100206 White, 2012, Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression, Res Synth Methods, 3, 111, 10.1002/jrsm.1045 Salanti, 2011, Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial, J Clin Epidemiol, 64, 163, 10.1016/j.jclinepi.2010.03.016 Turner, 2012, Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews, Int J Epidemiol, 41, 818, 10.1093/ije/dys041 Bucher, 1997, The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials, J Clin Epidemiol, 50, 683, 10.1016/S0895-4356(97)00049-8 Veroniki, 2013, Evaluation of inconsistency in networks of interventions, Int J Epidemiol, 42, 332, 10.1093/ije/dys222 Dias, 2010, Checking consistency in mixed treatment comparison meta-analysis, Stat Med, 29, 932, 10.1002/sim.3767 Higgins, 2012, Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies, Res Synth Methods, 3, 98, 10.1002/jrsm.1044 Booth, 2011, An international registry of systematic-review protocols, Lancet, 377, 108, 10.1016/S0140-6736(10)60903-8 Leon, 2001, Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting, N Engl J Med, 344, 250, 10.1056/NEJM200101253440402 Popma, 2002, Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis, Circulation, 106, 1090, 10.1161/01.CIR.0000027814.96651.72 Silber, 2005, Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosis, Am Heart J, 149, 689, 10.1016/j.ahj.2004.05.061 Reynen, 2006, Intracoronary radiotherapy with a 188Rhenium liquid-filled angioplasty balloon system in in-stent restenosis: a single-center, prospective, randomized, placebo-controlled, double-blind evaluation, Coron Artery Dis, 17, 371, 10.1097/00019501-200606000-00008 vom Dahl, 2002, Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST), Circulation, 105, 583, 10.1161/hc0502.103347 Dietz, 2002, Angiographic analysis of the angioplasty versus rotational atherectomy for the treatment of diffuse in-stent restenosis trial (ARTIST), Am J Cardiol, 90, 843, 10.1016/S0002-9149(02)02705-4 Haager, 2003, Catheter Cardiovasc Interv, 60, 25, 10.1002/ccd.10627 Sharma, 2004, Randomized trial of Rotational Atherectomy Versus Balloon Angioplasty for Diffuse In-stent Restenosis (ROSTER), Am Heart J, 147, 16, 10.1016/j.ahj.2003.07.002 Alfonso, 2003, A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis, J Am Coll Cardiol, 42, 796, 10.1016/S0735-1097(03)00852-0 Alfonso, 2004, Therapeutic implications of in-stent restenosis located at the stent edge. Insights from the Restenosis Intra-stent Balloon Angioplasty Versus Elective Stenting (RIBS) randomized trial, Eur Heart J, 25, 1829, 10.1016/j.ehj.2004.07.019 Alfonso, 2005, Long-term results (three to five years) of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Stenting (RIBS) randomized study, J Am Coll Cardiol, 46, 756, 10.1016/j.jacc.2005.05.050 Ragosta, 2004, Percutaneous treatment of focal vs diffuse in-stent restenosis: a prospective randomized comparison of conventional therapies, Catheter Cardiovasc Interv, 61, 344, 10.1002/ccd.10779 Alfonso, 2005, Repeat stenting for the prevention of the early lumen loss phenomenon in patients with in-stent restenosis. Angiographic and intravascular ultrasound findings of a randomized study, Am Heart J, 149, e1, 10.1016/j.ahj.2004.06.022 Kastrati, 2005, Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial, JAMA, 293, 165, 10.1001/jama.293.2.165 Alfonso, 2006, A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial, J Am Coll Cardiol, 47, 2152, 10.1016/j.jacc.2005.10.078 Alfonso, 2008, Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. Elective Sirolimus-eluting Stenting) study, J Am Coll Cardiol, 52, 1621, 10.1016/j.jacc.2008.08.025 Holmes, 2006, Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial, JAMA, 295, 1264, 10.1001/jama.295.11.1264 Holmes, 2008, 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-stent Restenosis) trial, JACC Cardiovasc Interv, 1, 439, 10.1016/j.jcin.2008.05.010 Alli, 2012, Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-stent Restenosis (SISR) trial, Am Heart J, 163, 438, 10.1016/j.ahj.2011.11.019 Stone, 2006, Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial, JAMA, 295, 1253, 10.1001/jama.295.11.1253 Ellis, 2008, Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial, Eur Heart J, 29, 1625, 10.1093/eurheartj/ehn231 Schukro, 2007, Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis, Radiother Oncol, 82, 18, 10.1016/j.radonc.2006.08.016 Park, 2008, Treatment of diffuse in-stent restenosis with drug-eluting stents vs. intracoronary beta-radiation therapy: INDEED study, Int J Cardiol, 131, 70, 10.1016/j.ijcard.2007.09.003 Mehilli, 2010, Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study, J Am Coll Cardiol, 55, 2710, 10.1016/j.jacc.2010.02.009 Chevalier, 2012, One-year results of the CRISTAL trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents, J Interv Cardiol, 25, 586, 10.1111/j.1540-8183.2012.00769.x Song, 2012, Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation, J Am Coll Cardiol, 59, 1093, 10.1016/j.jacc.2011.11.047 Alfonso, 2014, J Am Coll Cardiol, 63, 1378, 10.1016/j.jacc.2013.12.006 Alfonso, 2015, A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial, J Am Coll Cardiol, 66, 23, 10.1016/j.jacc.2015.04.063 Scheller, 2006, Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter, N Engl J Med, 355, 2113, 10.1056/NEJMoa061254 Scheller, 2008, Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter, Clin Res Cardiol, 97, 773, 10.1007/s00392-008-0682-5 Scheller, 2012, Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter, JACC Cardiovasc Interv, 5, 323, 10.1016/j.jcin.2012.01.008 Unverdorben, 2009, Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis, Circulation, 119, 2986, 10.1161/CIRCULATIONAHA.108.839282 Habara, 2011, Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis, JACC Cardiovasc Interv, 4, 149, 10.1016/j.jcin.2010.10.012 Rittger, 2012, A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study, J Am Coll Cardiol, 59, 1377, 10.1016/j.jacc.2012.01.015 Habara, 2013, A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis, Am Heart J, 166, 527, 10.1016/j.ahj.2013.07.002 Byrne, 2013, Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial, Lancet, 381, 461, 10.1016/S0140-6736(12)61964-3 Xu, 2014, A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial, JACC Cardiovasc Interv, 7, 204, 10.1016/j.jcin.2013.08.011 Salanti, 2014, Evaluating the quality of evidence from a network meta-analysis, PLoS One, 9, e99682, 10.1371/journal.pone.0099682 Windecker, 2014, Eur Heart J, 35, 2541, 10.1093/eurheartj/ehu278 Stefanini, 2013, Drug-eluting coronary-artery stents, N Engl J Med, 368, 254, 10.1056/NEJMra1210816 Räber, 2012, Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study, Circulation, 125, 1110, 10.1161/CIRCULATIONAHA.111.058560 Bangalore, 2012, Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials, Circulation, 125, 2873, 10.1161/CIRCULATIONAHA.112.097014 Pilgrim, 2014, Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial, Lancet, 384, 2111, 10.1016/S0140-6736(14)61038-2 Richardt, 2013, Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis, JACC Cardiovasc Interv, 6, 905, 10.1016/j.jcin.2013.04.017 Smits, 2013, Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial, Lancet, 381, 651, 10.1016/S0140-6736(12)61852-2 Silber, 2011, Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial, Lancet, 377, 1241, 10.1016/S0140-6736(11)60395-4 Byrne, 2014, Drug-coated balloon therapy in coronary and peripheral artery disease, Nat Rev Cardiol, 11, 13, 10.1038/nrcardio.2013.165 Scheller, 2004, Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis, Circulation, 110, 810, 10.1161/01.CIR.0000138929.71660.E0 Piccolo, 2014, Meta-analysis of randomized trials comparing the effectiveness of different strategies for the treatment of drug-eluting stent restenosis, Am J Cardiol, 114, 1339, 10.1016/j.amjcard.2014.07.069 Lee, 2015, Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized, controlled trials, JACC Cardiovasc Interv, 8, 382, 10.1016/j.jcin.2014.09.023 Campo, 2014, Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia), J Am Coll Cardiol, 63, 506, 10.1016/j.jacc.2013.09.043 Mills, 2013, Demystifying trial networks and network meta-analysis, BMJ, 346, f2914, 10.1136/bmj.f2914 Kang, 2011, Mechanisms of in-stent restenosis after drug-eluting stent implantation: intravascular ultrasound analysis, Circ Cardiovasc Interv, 4, 9, 10.1161/CIRCINTERVENTIONS.110.940320